Our second crowdsourcing campaign in partnership with Wazoku is getting closer to the end. There’s only one month before submissions are closed! This Open Innovation Challenge aims to identify innovative Drug Delivery Systems (DDS) and Treatment Approaches to significantly improve the lives of people with epilepsy, especially elderly and pediatric patients. Research is key and any help from researchers, scientists, and PhD students is vital for progress. If you have novel approaches to using available anti-seizure medications for patients with epilepsy, we need your help. The challenge closes in a month, on August 26. Good luck! To know more: https://lnkd.in/dJvgkyjr #AngeliniPharma #EveryStepCloser #WithYouInMind
Angelini Pharma
Farmaceutická výroba
Rome, RM 133 687 sledující uživatelů
Our passion for science leads us everyday to care for people's health.
O nás
At Angelini Pharma, we work every day to grow as a leading Pharma Company that makes a difference in patients’ life. Since 1919. We aim at becoming a leading European player, offering people, patients and their beloved ones new medicines and solutions to achieve better health outcomes and higher quality of life. We make our vision real through robust pipeline growth, strong collaborations with best-in-class Research Institutes and valuable partnerships with our strategic allies. We pledge to successfully develop distinctive treatments for CNS and Mental Health disorders while preserving our leading position in the Consumer Health segment. Angelini Pharma is part of Angelini Industries. Social media privacy notice: https://bit.ly/socialmediaprivacynotice
- Web
-
https://www.angelinipharma.com/
Externí odkaz pro organizaci Angelini Pharma
- Obor
- Farmaceutická výroba
- Velikost společnosti
- 5 001–10 000 zaměstnanců
- Ústředí
- Rome, RM
- Typ
- Soukromá společnost
- Datum založení
- 1919
- Speciality
- consumer healthcare, brain health, epilepsy a mental health
Lokality
Zaměstnanci společnosti Angelini Pharma
Aktualizace
-
At Angelini Pharma, we care for people’s health every single day. We invest in research and education to foster growth and create lasting value for a healthier society. We proudly present our 2023 key financial results, showcasing our dedication to global health and a significant step towards realizing our vision. Driven by our commitment to advancing healthcare and improving quality of lives, we thank our team and partners for their continued support and hard work. Here's to our shared data: https://lnkd.in/dKSQQPkU #AngeliniPharma #EveryStepCloser
-
Today is World Brain Day: a global initiative promoted by the World Federation Of Neurology to raise awareness on brain health and neurological disorders. This year’s focus being prevention, we decided to celebrate by going practical, always with the special involvement of our people. Here’s a collection of tips to maintain good brain health, with the words of Bioanalytical Study Manager Patrizia Dragone, Senior Study Manager Valeria Tellone, and Senior Clinical Fellow John Paul Leach. #AngeliniPharma #EveryStepCloser #WithYouInMind #WorldBrainDay2024
-
On World Brain Day, we continue our exploration of the topic, with the help of our expert voices. With Global Medical Advisor Valeria Di Franco, we delve into the importance of spreading information widely, with an education activity that includes schools, workplaces, and media channels. #AngeliniPharma #EveryStepCloser #WithYouInMind #WorldBrainDay2024 World Federation Of Neurology
-
July 22nd is World Brain Day: an annual event promoted by the World Federation Of Neurology aimed at promoting awareness and education for neurological disorders that affect individuals worldwide. This year's theme is Prevention and we decided to get our people involved and explore this delicate topic together. We start with Pharmacokinetics researcher Marcello C. Laurenti, with whom we get over some of the most important numbers concerning brain health, as well as exploring what prevention means. #AngeliniPharma #EveryStepCloser #WithYouInMind #WorldBrainDay2024
-
Celebrating our collective achievements with our Group. As Angelini Pharma, we are proud in contributing to the positive 2023 results of Angelini Industries. For a detailed overview of the results, please visit the press release here: https://lnkd.in/ewmdiEbi 🇮🇹 Celebriamo i successi del nostro Gruppo. Ad Angelini Pharma siamo orgogliosi di contribuire ai risultati positivi del 2023 di Angelini Industries. Per maggiori dettagli sui risultati, potete visitare il comunicato stampa: https://lnkd.in/e7K22fBn #AngeliniPharma #EveryStepCloser
🇮🇹 L'Assemblea dei Soci di Angelini Holding, la capogruppo di Angelini Industries, ha approvato il bilancio consolidato dell'esercizio 2023, che si chiude con una sensibile crescita rispetto ai valori di fine 2022. Infatti, per la prima volta nella storia del Gruppo, i ricavi sono pari a euro 2.149,6 milioni. Un risultato che si inserisce in un percorso di costante crescita che ha caratterizzato gli ultimi 4 anni di Angelini Industries. Il CEO, Sergio Marullo di Condojanni: "Fondamentali gli investimenti in innovazione e ricerca, strategiche le acquisizioni nel Pharma e nella Tecnologia Industriale. Focus sulla crescita anche in futuro". 👉 Leggi il comunicato stampa: https://lnkd.in/e7K22fBn 🇬🇧 The Shareholders' Meeting of Angelini Holding, the parent company of Angelini Industries, approved the consolidated financial statements for FY 2023, which closed with considerable growth compared to the end of 2022. For the first time in the Group's history, revenues amounted to 2,149.6 million euros, an increase of over 7% compared to 2022. This result is part of a process of constant growth that characterized Angelini Industries' last 4 years. CEO Sergio Marullo di Condojanni stated, "Investments in innovation and research have been fundamental, acquisitions in Pharma and Industrial Technology, strategic. Further focus on future growth". 👉 Read the press release: https://lnkd.in/ewmdiEbi #AngeliniIndustries #IndustryOfCare #AnnualReport
-
-
We are thrilled to share that we achieved the Legal Team International Expansion of the year award, as part of the XI Edition of TopLegal Corporate Counsel Awards. Thanks to TopLegal for recognizing our commitment and dedication in building a company focused on improvement and growth. A special thanks to Enza Maria Cristina Onnis and our Global Legal & Compliance Team. Our everyday promise is to stay focused on our patients’ needs and on the future of our company. #AngeliniPharma #EveryStepCloser
-
-
Today we officially launch "#FuturePills", our monthly newsletter dedicated to the latest advancements in pharmaceuticals and medicine. In this first edition, we dive deep into neurotechnology innovations and new findings regarding epilepsy, we explore the role of positive emotions and experiences in brain health... and so much more. Subscribe to get access to a monthly dose of good news from the pharma world, and feel free to share with anyone you think might be interested!
-
As part of our ongoing effort to raise awareness and promote education about #epilepsy, we explore the seizure spectrum and delve deep into the epileptic pathways. In the hope that it can be a useful resource to gain a comprehensive understanding of epilepsy and its impact on the lives of those who suffer from it. https://lnkd.in/dK_SFpEj #AngeliniPharma #EveryStepCloser #WithYouInMind
-
In partnership with The European House-Ambrosetti, we launched Headway: A new roadmap in Brain Health, a project that aims to create a common ground for strategic reflection and dialogue on Epilepsy and Mental Health, as experienced from different European perspectives. Today 1st July, Headway is in Helsinki, welcoming local and global experts to talk about the implementation of the Intersectoral Global Action Plan on epilepsy & other neurological disorders (IGAP), with a special focus on how to break the barriers of stigma, fostering inclusion and rights for people with epilepsy. #AngeliniPharma #EveryStepCloser #WithYouInMind